Tityus stigmurus-Venom-Loaded Cross-Linked Chitosan Nanoparticles Improve Antimicrobial Activity

Fiamma Gláucia-Silva,João Vicente Pereira Torres,Manoela Torres-Rêgo,Alessandra Daniele-Silva,Allanny Alves Furtado,Sarah de Sousa Ferreira,Guilherme Maranhão Chaves,Francisco Humberto Xavier-Júnior,Karla Samara Rocha Soares,Arnóbio Antônio da Silva-Júnior,Matheus de Freitas Fernandes-Pedrosa
DOI: https://doi.org/10.3390/ijms25189893
IF: 5.6
2024-09-14
International Journal of Molecular Sciences
Abstract:The rapid resistance developed by pathogenic microorganisms against the current antimicrobial pool represents a serious global public health problem, leading to the search for new antibiotic agents. The scorpion Tityus stigmurus, an abundant species in Northeastern Brazil, presents a rich arsenal of bioactive molecules in its venom, with high potential for biotechnological applications. However, venom cytotoxicity constitutes a barrier to the therapeutic application of its different components. The objective of this study was to produce T. stigmurus-venom-loaded cross-linked chitosan nanoparticles (Tsv/CN) at concentrations of 0.5% and 1.0% to improve their biological antimicrobial activity. Polymeric nanoparticles were formed with a homogeneous particle size and spherical shape. Experimental formulation parameters were verified in relation to mean size ( 78%). Tsv/CN 1.0% demonstrated an ability to increase the antimicrobial venom effect against Staphylococcus aureus bacteria, exhibiting an MIC value of 44.6 μg/mL. It also inhibited different yeast species of the Candida genus, and Tsv/CN 0.5% and 1.0% led to a greater inhibitory effect of C. tropicalis and C. parapsilosis strains, presenting MIC values between 22.2 and 5.5 μg/mL, respectively. These data demonstrate the biotechnological potential of these nanosystems to obtain a new therapeutic agent with potential antimicrobial activity.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?